CrowdStrike Holdings, Inc. ⋅ 10-Q ⋅ 6/4 CIENA CORP ⋅ 10-Q ⋅ 6/4 Keysight Technologies, Inc. ⋅ 10-Q ⋅ 6/4 DICK'S SPORTING GOODS, INC. ⋅ 10-Q ⋅ 6/4 lululemon athletica inc. ⋅ 10-Q ⋅ 6/4 FIVE BELOW, INC ⋅ 10-Q ⋅ 6/4 X-Energy, Inc. ⋅ 10-Q ⋅ 6/4 ARGAN INC ⋅ 10-Q ⋅ 6/4 TORO CO ⋅ 10-Q ⋅ 6/4 Macy's, Inc. ⋅ 10-Q ⋅ 6/4

CrowdStrike Holdings, Inc. ⋅ 10-Q ⋅ 6/4 CIENA CORP ⋅ 10-Q ⋅ 6/4 Keysight Technologies, Inc. ⋅ 10-Q ⋅ 6/4 DICK'S SPORTING GOODS, INC. ⋅ 10-Q ⋅ 6/4 lululemon athletica inc. ⋅ 10-Q ⋅ 6/4 FIVE BELOW, INC ⋅ 10-Q ⋅ 6/4 X-Energy, Inc. ⋅ 10-Q ⋅ 6/4 ARGAN INC ⋅ 10-Q ⋅ 6/4 TORO CO ⋅ 10-Q ⋅ 6/4 Macy's, Inc. ⋅ 10-Q ⋅ 6/4

MoonLake Immunotherapeutics

Pharmaceutical Preparations | SIC: 2834
Phone: 41 41 510 8022

CIK: 0001821586
State Location: V8
State of Inc.: E9

Nasdaq:MLTX

Form: SCHEDULE 13D/A

Filing Date: 02 Apr 2026
Report Date:
Accepted: 02 Apr 2026 02:44 p.m.
Accession Number: 0000921895-26-000894

Act: 34
File Number: 005-91803
Film Number: 26834661

Documents

Primary Document

Accepted: 02 Apr 2026 02:44 p.m.

0000921895-26-000894-index-headers.html

Last Modified: 02 Apr 2026 02:44 p.m.

0000921895-26-000894-index.html

Last Modified: 02 Apr 2026 02:44 p.m.

0000921895-26-000894.txt

Last Modified: 02 Apr 2026 02:44 p.m.

primary_doc.xml

Last Modified: 02 Apr 2026 02:44 p.m.